Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma

Clinical trial NCT02227108 · TERMINATED

Trial details

NCT number: NCT02227108
Sponsor: MedImmune LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

B-Cell Pediatric ALL

Start date: 2014-08-01
Primary completion: 2015-11-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.